Ophthalmic Use of Targeted Biologics in the Management of Intraocular Diseases: Current and Emerging Therapies

Ophthalmic Use of Targeted Biologics in the Management of Intraocular Diseases: Current and Emerging Therapies

Background: Monoclonal antibodies (mAbs) have demonstrated substantial potential in the treatment of intraocular diseases. This review aimed to comprehensively evaluate the applications, efficacy, and safety of mAbs in the management of intraocular conditions. Methods: A comprehensive literature sea...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yuan Zong, Miki Miyagaki, Mingming Yang, Jing Zhang, Yaru Zou, Kyoko Ohno-Matsui, Koju Kamoi
Format:	Article
Language:	English
Published:	MDPI AG 2024-10-01
Series:	Antibodies
Subjects:	monoclonal antibodies (mAbs) anti-VEGF therapy intraocular diseases non-infectious uveitis age-related macular degeneration (AMD) retinal vein occlusion (RVO)
Online Access:	https://www.mdpi.com/2073-4468/13/4/86
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Outcomes of Anti-VEGF Therapy in Eyes with Diabetic Macular Edema, Vein Occlusion-Related Macular Edema, and Neovascular Age-Related Macular Degeneration: A Systematic Review
by: Aldokhail LS, et al.
Published: (2024-12-01)

Functional and Anatomical Outcomes of Faricimab in Previously Treated Wet Age-Related Macular Degeneration: Systematic Review and Pooled Analysis
by: Ali Khodor, et al.
Published: (2025-07-01)

Selection of Endpoints for Clinical Studies of Ophthalmic Drugs
by: M. O. Komarova
Published: (2021-10-01)

The Economic Burden of Anti-Vascular Endothelial Growth Factor on Patients and Caregivers in the UK, Europe, and North America
by: David Tabano, et al.
Published: (2025-06-01)

Adherence to Anti-VEGF Treatment in Patients with Neovascular Age-Related Macular Degeneration: A Real-World Study
by: Mekala Shellvarajah, et al.
Published: (2025-04-01)

Real-World 5-Year Outcomes of Age-Related Macular Degeneration with Bevacizumab as First-Line Anti-VEGF
by: H. Mhmud, et al.
Published: (2025-06-01)

Efficacy and Safety of Aflibercept Biosimilars Relative to Reference Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
by: Aljuhani HS, et al.
Published: (2025-06-01)

Etiopathogenesis of non-exudative age-related macular degeneration (literature review)
by: M. M. Bikbov, et al.
Published: (2022-03-01)

Efficacy and safety of dexamethasone versus intravitreal aflibercept implants for macular edema: a systematic review and meta-analysis
by: Khaled Moghib, et al.
Published: (2025-04-01)

Brolucizumab in patients with neovascular age-related macular degeneration: Real-life outcomes from a tertiary care eye hospital
by: Lorenzo Fabozzi, et al.
Published: (2024-11-01)

The Efficacy of Targeted Monoclonal IgA Antibodies Against Pancreatic Ductal Adenocarcinoma
by: Léon Raymakers, et al.
Published: (2025-04-01)

Antioxidants in Age-Related Macular Degeneration: Lights and Shadows
by: Uday Pratap Singh Parmar, et al.
Published: (2025-01-01)

Efficacy and Safety of Nutraceutical Support in Age-Related Macular Degeneration Patients
by: S. V. Yanchenko, et al.
Published: (2023-01-01)

Berries and Their Active Compounds in Prevention of Age-Related Macular Degeneration
by: Xiang Li, et al.
Published: (2024-12-01)

The role of peripheral blood microRNAs in the pathogenesis and treatment response of age-related macular degeneration
by: Meng Kong, et al.
Published: (2025-12-01)

The nonglycosylated variant in therapeutic monoclonal antibodies preferentially forms large aggregates under typical thermal stresses used in forced degradation studies
by: Gao-Yuan Liu, et al.
Published: (2025-12-01)

Expanding Application of Optical Coherence Tomography Beyond the Clinic: A Narrative Review
by: Tutut Nurjanah, et al.
Published: (2025-04-01)

Treatment Methods Dry Form of Age Macular Degeneration — History and Prospects. Review
by: A. N. Kulikov, et al.
Published: (2023-10-01)

Investigation of PANoptosis pathway in age-related macular degeneration triggered by Aβ1-40
by: Yuxia He, et al.
Published: (2025-04-01)

Plasma and Urine Metabolites Associated with Microperimetric Retinal Sensitivity in Age-Related Macular Degeneration
by: Krupa Sourirajan, et al.
Published: (2025-03-01)

A high-fat plus high-sucrose diet induces age-related macular degeneration in an experimental rabbit model
by: Yujiao Wang, et al.
Published: (2024-11-01)

Vitrectomy for full-thickness macular hole developed during aflibercept treatment for wet age-related macular degeneration
by: Agnieszka Nowosielska
Published: (2024-12-01)

Consensus SEO-SEFH of recommendations for use and compounding of ophthalmic preparations
by: Raquel Fuentes-Irigoyen, et al.
Published: (2018-03-01)

Real-world outcomes of a loading phase with intravitreal faricimab in refractory Neovascular Age-Related Macular Degeneration (nAMD) patients
by: Xu Yufeng, et al.
Published: (2025-07-01)

Dynamics of Structural and Functional Changes of Patients with Dry Form Age-related Macular Degeneration after Double Filtration Plasmapheresis
by: A. A. Volozhev, et al.
Published: (2024-04-01)

Dynamics of visual acuity, optical coherence tomography (OСT) and OСT angiography indicators of patients with dry form of age-related macular degeneration using double filtration plasmapheresis
by: A. A. Volozhev, et al.
Published: (2025-03-01)

Modifiable Lifestyle Risk Factors and Strategies for Slowing the Progression of Age-Related Macular Degeneration
by: Khushi Saigal, et al.
Published: (2025-02-01)

Analysis of Clinical Study Results Obtained in Patients with Neovascular Age-Related Macular Degeneration in 2005–2020. Review
by: N. A. Gavrilova, et al.
Published: (2022-04-01)

Implantation of the First IMT Macular Lens in Age-Related Macular Degeneration (Literature Review)
by: M. M. Bikbov, et al.
Published: (2019-08-01)

Does uveitis increase the risk of age-related wet macular degeneration? A Mendelian randomization study
by: Rui-Hua Jing, et al.
Published: (2025-08-01)

Exploiting Microperimetry as a Functional End Point in Healthy Aging and Different Stages of Age-Related Macular Degeneration
by: Johannes Schrittwieser, MD, et al.
Published: (2025-11-01)

Genotype Prediction from Retinal Fundus Images Using Deep Learning in Eyes with Age-Related Macular Degeneration
by: Avishai Halev, PhD, et al.
Published: (2025-11-01)

Non-Invasive Diagnosis of Polypoidal Choroidal Vasculopathy as a Variant of the Course of Age-Related Macular Degeneration
by: I. E. Panova, et al.
Published: (2018-07-01)

Retinal sensitivity above macular neovascularization under anti-VEGF therapy in exudative neovascular age-related macular degeneration
by: Laurenz Pauleikhoff, et al.
Published: (2025-03-01)

Significance of Biomarkers of Endothelial Dysfunction in Central Retinal Vein Occlusion
by: K. I. Belskaya, et al.
Published: (2024-10-01)

LMI-SI and Scharioth Additional Intraocular Lenses for Age-Related Macular Degeneration. Review
by: M. M. Bikbov, et al.
Published: (2019-04-01)

Fc glycan sialylation of biotherapeutic monoclonal antibodies has limited impact on antibody‐dependent cellular cytotoxicity
by: Elaine Branstetter, et al.
Published: (2021-11-01)

Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies
by: Merve Celik Yamaci, et al.
Published: (2025-04-01)

Targeting Soluble Amyloid Oligomers in Alzheimer’s Disease: A Hypothetical Model Study Comparing Intrathecal Pseudodelivery of mAbs Against Intravenous Administration
by: Manuel Menendez-Gonzalez
Published: (2025-01-01)

Revolutionary drug repositioning: the preventive and therapeutic potential of metformin and other antidiabetic drugs in age-related macular degeneration
by: Yating Zhou, et al.
Published: (2024-12-01)